Sun Pharmaceutical Industries Ltd , India's largest drugmaker by revenue, on Friday reported a 29.6% rise in fourth-quarter ...

Intas Pharmaceuticals Limited has informed that its manufacturing facility SEZ (Pharmez) near Ahmedabad has been listed under ‘Import Alert’ by the US Food and Drug Administration (USFDA).

The catalyst behind this market excitement was an activist 13D filing by Indian drugs giant Sun Pharmaceutical Industries (IN:SUNPHARMA). Sun Pharma presented a proposal offering to acquire ...

Shares declined nearly 2.5% in Monday's trading before recouping most of its losses. The stock eventually closed at ₹968.50, ...

Analysing the trends emerging from the fourth quarter results of pharma companies, brokerage firm Nuvama Institutional ...

Premium A security guard stands near Sun Pharmaceutical ... NDAs while 13 NDAs await US FDA approval. The company also completed the acquisition of Concert Pharmaceuticals, Inc during March ...

Shares of Taro Pharmaceutical Industries jumped more than 25% in premarket trading Tuesday after majority shareholder Sun Pharmaceutical Industries disclosed that it had made a proposal to buy the ...

The agency placed the factory under an import alert, meaning US-destined products may be detained ... the most in four months ...

(Reuters) -The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's drug for a broad treatment of heart failure, including in adult patients with type 2 diabetes, the ...

US inspectors have in recent months uncovered wide-ranging lapses at factories run by some of India’s biggest pharmaceutical ... letters by the US Food and Drug Administration, which is ...